X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Torrent Pharma Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Quarterly Results   (TORR)

Here are the latest quarterly results of Torrent Pharma. For more details, see the Torrent Pharma financial fact sheet and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Torrent Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m16,91015,39014,99015,45014,29014,43014,34013,740 
Other income Rs m7405102402604305001,0401,050 
Turnover Rs m17,65015,90015,23015,71014,72014,93015,38014,790 
Expenses Rs m9,7709,26010,15011,08010,99011,27011,39010,770 
Gross profit Rs m7,1406,1304,8404,3703,3003,1602,9502,970 
Depreciation Rs m610610650680690730970800 
Interest Rs m480420380490510480580560 
Profit before tax Rs m6,7905,6104,0503,4602,5302,4502,4402,660 
Tax Rs m1,640780480540460160380780 
Profit after tax Rs m5,1504,8303,5702,9202,0702,2902,0601,880 
Gross profit margin %42.239.832.328.323.121.920.621.6 
Effective tax rate %24.213.911.915.618.26.515.629.3 
Net profit margin %30.531.423.818.914.515.914.413.7 
Diluted EPS Rs 30.4 28.5 21.1 17.3 12.2 13.5 12.2 11.1  
Diluted EPS (TTM) Rs 74.5 93.2 106.6 97.3 79.1 64.1 55.2 49.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   WYETH LTD  TTK HEALTHCARE  ORCHID PHARMA LTD  ALKEM LABORATORIES  SUN PHARMA  

Compare TORRENT PHARMA With:   WYETH LTD  TTK HEALTHCARE  ORCHID PHARMA LTD  ALKEM LABORATORIES  SUN PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Elections in Germany, NTPC, PNB Share Price & Other Top Cues in Action Today(Pre-Open)

Indian share markets languished in red in previous session as rupee hit its weakest point since early April amid concerns that the government's plan for an impetus to halt an economic slowdown.

Views on news

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Rule-Based Investing Can Make A Lot of Money(The 5 Minute Wrapup)

Sep 16, 2017

We take a glimpse of Equitymaster's results from rule based investing.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Gold Imports Surge: Are People Hedging the Risk of Another Demonetisation?(Vivek Kaul's Diary)

Sep 19, 2017

Imports of the yellow metal have surged big time this year.

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

A Little-Known Japanese Secret for Compounding Wealth

Sep 22, 2017

What Warren Buffett and Benjamin Graham have in common with a little known Japanese secret.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Sep 22, 2017 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS